writing
-
The Hidden Variable Inside MedTech Scale-Ups Right Now
In the previous article, I wrote about the moment optionality begins to narrow in MedTech scale-ups. The natural question for boards is what determines whether that shift is recognised early, or only noticed once timelines begin to stretch. Across portfolios, the answer is rarely capital, rarely technology, and it is almost never effort. The hidden…
-
The Moment Optionality Begins to Narrow in MedTech Scale-Ups
A MedTech company can feel as though it is moving closer to market, while at the same time moving closer to only one version of its market. That difference is easy to miss. Early in a scale-up journey, optionality feels almost unlimited. Multiple regulatory paths look possible. Several clinical strategies appear sensible. Different positioning stories…
-
The Gap Between How AI Is Built and How It Will Be Assessed
Most AI MedTech companies are doing the right things, just in a way regulators will not recognise. Internally, everything feels controlled; externally, it will be judged by a very different standard. That gap widens fastest in companies moving quickly, led by capable teams who assume alignment will catch up later. But it rarely does. How…
Harun Rabbani 